Trihexyphenidyl
What is it: An anticholinergic solution targeting spasticity and dystonia for improved mobility.AKA: Artane, Benzhexol, Benzhexol hydrochloride- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
4 Resources
Referenced in this guide
16 Research papers
Referenced in this guide
4 Expert views
Contributed in this guide
9 Patient views
Contributed in this guide
Figure out what Trihexyphenidyl means for you
Page contents
Basics: What you need to know
Trihexyphenidyl is a centrally acting anticholinergic agent used in carefully managed doses to address movement-related symptoms. In people with cerebral palsy, it is primarily prescribed to lessen involuntary muscle contractions and improve overall mobility. Although it is standardized for clinical use, it requires careful administration and monitoring.
History and development
- Early creation: Trihexyphenidyl was first synthesized in the mid-20th century for Parkinson’s disease, specifically to reduce tremors and rigidity.
- Shift to wider use: Over time, doctors observed it could benefit patients with various forms of dystonia and spasticity, ultimately influencing its adoption in treating certain forms of cerebral palsy.
- Refined dosages: As scientific understanding grew, clinicians refined dosing strategies and identified best practices, leading to improved outcomes, especially in pediatric treatments.
What is known
- Muscle regulation: By blocking certain chemical signals in the brain, Trihexyphenidyl helps regulate muscle movements, which can reduce spasms and enhance control over motor function.
- Symptom improvement: Patients often report a noticeable reduction in rigidity and abnormal postures, which can help with tasks like walking and holding objects.
- Secondary benefits: Some lesser-known advantages include reduced drooling and improved comfort during daily activities. These effects can indirectly contribute to better social engagement.
- Critical monitoring: Close observation of pulse, blood pressure, and cognition is vital, given Trihexyphenidyl’s effect on the nervous system.
What is not known
- Long-term impact: Although its effectiveness in movement disorders is established, gaps remain on the full spectrum of long-term neurological effects. More research is needed to clarify any potential cognitive changes over decades.
- Individual variation: Why some individuals respond more favorably than others is not fully understood, suggesting a need for personalized dosing methods.
- Optimal usage protocols: The best combination with other therapies, such as physical rehabilitation or botulinum toxin injections, is still under investigation, leaving clinicians to decide case by case.
- Neuro-blocking mechanism: It reduces the excess activity of acetylcholine in the nervous system.
- Motor control improvement: This shift in neurotransmitter balance can lead to smoother, more controlled movements.
- Spasticity reduction: The medication lowers rigid muscle tone, enhancing comfort and range of motion.
- Assistive synergy: It often works alongside therapies like stretching or physical rehabilitation.
- Dry mouth: A common issue due to decreased saliva production.
- Blurred vision: May require adjustments in daily activities like reading.
- Memory changes: Possible mild confusion or forgetfulness in certain individuals.
- Constipation risk: Reduced gut motility can lead to bowel irregularities.
- Dizziness or drowsiness: Can temporarily affect balance and alertness.
- Response variability: Some practitioners see variable success rates, demanding personalized management.
- Dose complexities: Adjusting the correct dose can be challenging, and trial-and-error methods are sometimes necessary.
- Side effect profile: Critics cite significant side effects like dry mouth and sedation, which can outweigh benefits in certain cases.
- Age-related concerns: Some experts worry about its prolonged use in younger patients due to potential developmental impacts.
Patient views
Experiences
- Patients appreciate improvements in fine motor skills and speech.
- Some report reduced involuntary movements and better stability.
- Many find it effective for managing dystonia symptoms.
- Few experience minimal or manageable side effects.
Challenges
- Common complaints include fatigue and dry mouth.
- Nightmares and sleep disturbances are reported by some.
- Some find it ineffective for long-term dystonia relief.
- Side effects like constipation and fuzzy feelings are noted.
Tips
- Start with a lower dose and adjust gradually.
- Monitor for sleep disturbances and adjust timing.
- Combine with other treatments like Botox or splints.
- Consult neurologists for personalized advice.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
My child has been taking trihexyphenidyl for over a year and she really has had no side effects. It's possible that it contributes to constipation, but we have that managed. I think it has helped with fine motor and verbal skills.
January 2024 • Turnto Comment
Patient view
We use trihexyphenadyl for dystonia. My spouse claims she sees an effect although I don't see that much. It's hard to tell over such a long period of time though
February 2025 • Turnto Comment
Expert views
What they liked
- Experts appreciate trihexyphenidyl's ability to improve movement in dystonic children.
- Positive effects on obsessive-compulsive symptoms were noted in one case study.
- Functional improvements in day-to-day activities were observed in some patients.
- Experts value its role in managing involuntary movements in dyskinetic cerebral palsy.
What they didn't like
- Side effects limit the dosage patients can tolerate.
- Evidence on its effectiveness remains inconsistent across studies.
- Lack of reliable measurement tools for outcomes in cerebral palsy.
- Limited duration of treatment reduces detection of potential benefits.
What are they unsure about
- Experts are uncertain about optimal dosing for different age groups.
- Long-term effects of trihexyphenidyl remain unclear.
- Uncertainty about its impact on non-motor symptoms like learning tasks.
- Experts question its effectiveness across diverse movement patterns.
4 expert views
Expert view
Dr. Kathryn Peall discusses the use of Trihexyphenidyl (Artane) in treating movement disorders, including its application in cerebral palsy. She notes that while the medication showed some improvement in symptoms like dystonia and chorea, it did not completely eliminate them. A notable case involved a patient with obsessive-compulsive disorder (OCD) who experienced significant improvement in OCD symptoms while being treated with Trihexyphenidyl for dystonia. This improvement was particularly impactful during the patient's school exams. Dr. Peall also highlights the challenges in measuring treatment outcomes for rare conditions like cerebral palsy, emphasizing the need for better tools to assess both motor and non-motor functions.
July 2014 • Discussion of the paper, 'Benign hereditary chorea related to NKX2.1: expansion of the genotypic and phenotypic spectrum'.
Expert view
Dr. Charlie Fairhurst discussed the use of Trihexyphenidyl for children with dystonia, a movement disorder often associated with cerebral palsy. He noted that Trihexyphenidyl was chosen for its side effect profile, which includes improved movement. The treatment outcomes were comparable to other interventions like botulinum toxin injections, which showed improvement by a factor of 40 out of 100. Dr. Fairhurst also mentioned that oral anticholinergic medications, such as glycopyrrolate, improved conditions by about 20-22 out of 100.
May 2024 • EACD 2024 (Dr Charlie Fairhurst)
What and who it targets
Patients with spasticity
Addresses muscle stiffness and rigidity.
Patients with dystonia
Effective for managing involuntary muscle contractions.
Older children and adolescents
Better tolerance and response to medication.
Relevant research
How much evidence on this?
- Evidence spans over 20 years; mixed study designs.
- At least 10 studies, including randomized trials.
- Studies include systematic reviews and clinical trials.
- Research focuses on dystonia and sialorrhea in cerebral palsy.
Research focusing on
- Improves dystonia, motor function, and saliva control.
- Side effects include constipation and pseudo-obstruction.
- Gradual dose increases improve tolerability.
- Combination therapies (e.g., clonazepam) show promise.
What needs more research?
- Long-term effects on quality of life unclear.
- Optimal dosing regimens remain inconsistent.
- Efficacy varies by age and dystonia type.
- Limited data on pain and emotional outcomes.
- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
Research
This paper investigated the effects of trihexyphenidyl, a medication, on dystonia in individuals with cerebral palsy. The study focused on outcomes such as changes in dystonia, adverse effects, mobility, upper limb function, participation in daily activities, pain, and quality of life.
The study found no significant improvement in dystonia or upper limb function with trihexyphenidyl, but there was some evidence of improved participation in daily activities. However, the medication was associated with an increased risk of adverse effects, and the evidence quality was rated as low.
For individuals with cerebral palsy and their caregivers, this study suggests that trihexyphenidyl may not significantly reduce dystonia or improve motor function, but it might help with participation in daily activities. However, the potential for adverse effects and the low quality of evidence mean that its benefits and risks should be carefully weighed.
The study is a systematic review published in a reputable journal, The Cochrane Database of Systematic Reviews, which is known for rigorous methodologies. However, the findings are based on a single small trial with low-quality evidence, limiting the reliability of the conclusions.
May 2018 • The Cochrane database of systematic reviews
Research
This study reviewed the benefits and tolerability of trihexyphenidyl in children with cerebral palsy who were treated for dystonia, excessive drooling (sialorrhea), or both. Researchers conducted a retrospective chart review of 101 patients at a pediatric tertiary care hospital, analyzing their responses to the medication.
The study found that 91% of patients tolerated trihexyphenidyl well, with a mean treatment duration of 3 years and 7 months. Benefits included reduced dystonia in the arms (59.4%) and legs (37.6%), improved drooling (60.4%), and better speech (24.7%). Side effects occurred in 69% of patients, mostly in those aged 7 years or older, but 64% continued treatment by the study's end.
For children with cerebral palsy, trihexyphenidyl may offer significant improvements in movement issues, drooling, and speech, making daily life easier. Caregivers can be reassured that most children tolerate the medication well, though side effects are common and should be monitored closely.
This retrospective study provides valuable insights but has limitations, such as reliance on past records and lack of a control group. Published in a reputable journal, Pediatric Neurology, the findings are relevant but should be interpreted with caution due to the study design.
February 2011 • Pediatric neurology
Accessibility
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
Method to access
- Obtain a prescription from a healthcare provider.
- Available at most pharmacies and hospitals.
- Online pharmacies may also provide this medication with a valid prescription.
Cost
- In the US, prices range from $6 to $23 for a supply of 100 tablets (2 mg).
- Costs may vary slightly in other regions but are generally low.
Insurance cover
- Commonly covered by health insurance and government programs like Medicare in the US.
- Coverage may vary by country and insurance provider.
Locations
- Available at most local pharmacies and hospitals worldwide.
- Online pharmacies also offer this medication with a prescription.
Frequently asked questions
Key resources
Explore other treatments
It's a lot of information, isn't it?
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto
